Back

AstraZeneca CEO buys £7.26 million of shares as Klygefa gets EU recommendation

Verifying
  • Pascal Soriot bought 60,000 AstraZeneca ordinary shares.
  • £121.02 per share valued the transaction at more than £7.26 million.
  • Klygefa received a favorable CHMP assessment for eligible adults with generalised myasthenia gravis.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.